Immunome, Inc. (IMNM) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Bothell, PA, United States. The current CEO is Clay Siegall.
IMNM has IPO date of 2020-10-02, 131 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $2.01B.
No company description available.
